167 related articles for article (PubMed ID: 1708102)
21. A novel Plasmodium falciparum sporozoite and liver stage antigen (SALSA) defines major B, T helper, and CTL epitopes.
Bottius E; BenMohamed L; Brahimi K; Gras H; Lepers JP; Raharimalala L; Aikawa M; Meis J; Slierendregt B; Tartar A; Thomas A; Druilhe P
J Immunol; 1996 Apr; 156(8):2874-84. PubMed ID: 8609407
[TBL] [Abstract][Full Text] [Related]
22. Limited immunological recognition of critical malaria vaccine candidate antigens.
Good MF; Miller LH; Kumar S; Quakyi IA; Keister D; Adams JH; Moss B; Berzofsky JA; Carter R
Science; 1988 Oct; 242(4878):574-7. PubMed ID: 2902690
[TBL] [Abstract][Full Text] [Related]
23. Protective cellular immunity against P. falciparum malaria merozoites is associated with a different P7 and P8 residue orientation in the MHC-peptide-TCR complex.
Patarroyo ME; Salazar LM; Cifuentes G; Lozano JM; Delgado G; Rivera Z; Rosas J; Vargas LE
Biochimie; 2006 Feb; 88(2):219-30. PubMed ID: 16126320
[TBL] [Abstract][Full Text] [Related]
24. In vitro peptide immunization of target tax protein human T-cell leukemia virus type 1-specific CD4+ helper T lymphocytes.
Kobayashi H; Ngato T; Sato K; Aoki N; Kimura S; Tanaka Y; Aizawa H; Tateno M; Celis E
Clin Cancer Res; 2006 Jun; 12(12):3814-22. PubMed ID: 16778109
[TBL] [Abstract][Full Text] [Related]
25. Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors.
Ossendorp F; Mengedé E; Camps M; Filius R; Melief CJ
J Exp Med; 1998 Mar; 187(5):693-702. PubMed ID: 9480979
[TBL] [Abstract][Full Text] [Related]
26. Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide.
Cease KB; Margalit H; Cornette JL; Putney SD; Robey WG; Ouyang C; Streicher HZ; Fischinger PJ; Gallo RC; DeLisi C
Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4249-53. PubMed ID: 2438696
[TBL] [Abstract][Full Text] [Related]
27. Human immune response in Plasmodium falciparum malaria. Synthetic peptides corresponding to known epitopes of the Pf155/RESA antigen induce production of parasite-specific antibodies in vitro.
Chougnet C; Troye-Blomberg M; Deloron P; Kabilan L; Lepers JP; Savel J; Perlmann P
J Immunol; 1991 Oct; 147(7):2295-301. PubMed ID: 1717554
[TBL] [Abstract][Full Text] [Related]
28. Structural basis of antigenic specificity and design of new vaccines.
Arnon R; Van Regenmortel MH
FASEB J; 1992 Nov; 6(14):3265-74. PubMed ID: 1385242
[TBL] [Abstract][Full Text] [Related]
29. Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules.
Shirai M; Pendleton CD; Berzofsky JA
J Immunol; 1992 Mar; 148(6):1657-67. PubMed ID: 1371784
[TBL] [Abstract][Full Text] [Related]
30. Analysis of peptide binding patterns in different major histocompatibility complex/T cell receptor complexes using pigeon cytochrome c-specific T cell hybridomas. Evidence that a single peptide binds major histocompatibility complex in different conformations.
Bhayani H; Paterson Y
J Exp Med; 1989 Nov; 170(5):1609-25. PubMed ID: 2553848
[TBL] [Abstract][Full Text] [Related]
31. Immune response in mouse and malaria-exposed humans to peptides derived from Pf11-1, a highly repetitive megadalton protein of Plasmodium falciparum.
Scherf A; Behr C; Sarthou JL; Pla M; Rogier C; Trape JF; da Silva LP; Dubois P
Eur J Immunol; 1993 Jul; 23(7):1574-81. PubMed ID: 7686855
[TBL] [Abstract][Full Text] [Related]
32. Lack of Ir gene control in the immune response to malaria. I. A thymus-independent antibody response to the repetitive surface protein of sporozoites.
Schofield L; Uadia P
J Immunol; 1990 Apr; 144(7):2781-8. PubMed ID: 2138652
[TBL] [Abstract][Full Text] [Related]
33. T-cell epitopes in Pf155/RESA, a major candidate for a Plasmodium falciparum malaria vaccine.
Kabilan L; Troye-Blomberg M; Perlmann H; Andersson G; Högh B; Petersen E; Björkman A; Perlmann P
Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5659-63. PubMed ID: 2456577
[TBL] [Abstract][Full Text] [Related]
34. T helper epitopes enhance the cytotoxic response of mice immunized with MHC class I-restricted malaria peptides.
Widmann C; Romero P; Maryanski JL; Corradin G; Valmori D
J Immunol Methods; 1992 Oct; 155(1):95-9. PubMed ID: 1383348
[TBL] [Abstract][Full Text] [Related]
35. Helper and cytotoxic T cell responses of HIV type 1-infected individuals to synthetic peptides of HIV type 1 Rev.
Blazevic V; Ranki A; Krohn KJ
AIDS Res Hum Retroviruses; 1995 Nov; 11(11):1335-42. PubMed ID: 8573390
[TBL] [Abstract][Full Text] [Related]
36. Immune evasion in malaria: altered peptide ligands of the circumsporozoite protein.
Plebanski M; Lee EA; Hill AV
Parasitology; 1997; 115 Suppl():S55-66. PubMed ID: 9571691
[TBL] [Abstract][Full Text] [Related]
37. Anomalous reversed-phase high-performance liquid chromatographic behavior of synthetic peptides related to antigenic helper T cell sites.
Büttner K; Pinilla C; Appel JR; Houghten RA
J Chromatogr; 1992 Nov; 625(2):191-8. PubMed ID: 1282129
[TBL] [Abstract][Full Text] [Related]
38. Sporozoite malaria vaccine. Where do we stand?
Nussenzweig V; Nussenzweig S
Ann Parasitol Hum Comp; 1990; 65 Suppl 1():49-52. PubMed ID: 1702271
[TBL] [Abstract][Full Text] [Related]
39. HLA polymorphism and T cell recognition of a conserved region of p190, a malaria vaccine candidate.
Guttinger M; Romagnoli P; Vandel L; Meloen R; Takacs B; Pink JR; Sinigaglia F
Int Immunol; 1991 Sep; 3(9):899-906. PubMed ID: 1718405
[TBL] [Abstract][Full Text] [Related]
40. Helper-cytotoxic T lymphocyte (CTL) determinant linkage required for priming of anti-HIV CD8+ CTL in vivo with peptide vaccine constructs.
Shirai M; Pendleton CD; Ahlers J; Takeshita T; Newman M; Berzofsky JA
J Immunol; 1994 Jan; 152(2):549-56. PubMed ID: 8283036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
